Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Transcatheter Aortic Valve Replacement (TAVR)
Delivering on ease of use through a more predictable and streamlined procedural experience.
Facilitate implant depth accuracy
The cusp overlap view isolates the non-coronary cusp and elongates the left ventricular outflow tract, providing a greater visual separation between the basal annular plane and the conduction system, and an accurate, patient-specific anatomical view to assess and achieve target implant depth.1
Predictable valve deployment
Slow deployment starting from a supra-annular position allows the valve to descend to its target position, providing users with control over valve deployment and requiring minimal catheter manipulation, which minimizes the risk of interaction with the conduction system.
The cusp overlap technique with an optimized care pathway continues to show dependable clinical outcomes.*
Accuracy when it matters most
Devices used: 91.5% Evolut™ PRO+/8.0% Evolut™ PRO.
* This is an interim analysis of 400 main cohort patients. At the conclusion of the study, more than 650 patients will have been evaluated.
Accurate depth assessment at the NCC, facilitated with the cusp overlap technique, has resulted in single-digit pacemaker rates in several single-center and multicenter clinical studies.
Excludes patients with baseline implantable cardioverter defibrillator or pacemaker.
†Discharge rates.
TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker.
Explore the Evolut TAVR implant procedure on Medtronic Academy.
Find training modules, live cases, webinars, and more at your fingertips.
Explore our other procedural guidance and outcomes you can expect from the Evolut platform.
Grubb JK, Gada H, Mittal S, et al. Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights from the Optimize PRO Study. JACC Cardiovasc Interv. March 13, 2023;16(5):558-570.
Gada H. TAVR in Low Risk Patients. Presented at TVT 2019.
Gada H, et al. Reduction of Rates of Permanent Pacemaker Implantation With 34-MM Evolut™ R Using Cusp Overlap Technique. Presented at TCT Connect 2020.
Gada H, et al. Reproducibility of Cusp Overlap Technique to Reduce Permanent Pacemaker Implantation With Evolut™: The Latin American Experience. Presented at TCT Connect 2020.
Pisaniello AD, Makki HBE, Jahangeer S, Daniels MJ, Hasan R, Fraser DGW. Low Rates of Permanent Pacing Are Observed Following Self-Expanding Transcatheter Aortic Valve Replacement Using an Annular Plane Projection for Deployment. Circ Cardiovascular Interv. January 2021;14(1):e009258.
Mendiz OA, Noč M, Fava CM, et al. Impact of Cusp-Overlap View for TAVR with Self-Expandable Valves on 30 Day Conduction Disturbances, J Interv Cardiol. April 28, 2021;2021:9991528.